Categories associated with best practice:
The British Columbia Oral Cancer Prevention Program (BC OCPP) is a multifaceted initiative that aims to reduce the incidence, morbidity and mortality of oral cancer through the development, validation, and adoption of new techniques for early detection, risk assessment, and management of premalignant oral diseases and cancer. An integrated management structure was implemented to facilitate a step-wise referral pathway that guides community health professionals (a clinical infrastructure links community dental practices and referral centres) and improves access to experts in diagnosis for a better management of oral cancer from early dysplasia to frank malignancy.
Since the BC OCPP initiation, partnerships between scientists and clinicians have stimulated the development of new technologies aimed at removing barriers to early diagnosis including:
- Fluorescence Visualization
- Toluidine Blue
- Microsatellite Analysis
- High-resolution computer Imaging systems
- Salivary markers
- Genomic profiling for patient management
The BC OCPP’s website was ranked among the top web-based, healthcare professionals-addressed resources on screening for oral cancer housing heterogeneous information with the potential to improve the existing educational gaps among healthcare professionals (Varela-Centelles et al., 2014).
The impact of the 2008 ‘Clinical Practice Guideline for the Early Detection of Oral Cancer in BC’ was evaluated in February 2010 using a telephone survey conducted with 100 general dentists. The survey showed an increase in oral cancer screening among dental practitioners that were aware of the guidelines: 84% of the dentists who had seen the guidelines had integrated screening as part of routine exams, compared to 65% among those not aware of the guidelines.
One of the BC OCPP key approach is centered on an opportunistic screening network of dentists and surgeons. This network is linked through a centralized BC Oral Biopsy Service (BC OBS) located in Vancouver BC that facilitates patient management and referrals. Change in usage in this service between 2007 (the year before the guideline’s release) and 2014 (last complete year of data) has been monitored and the following results were observed:
- Total number of biopsies received via OBS increased by 31% between 2007 (4484) and 2014 (5866)
- Number of ‘possible oral premalignant lesions’ (this includes all SCC, CIS, dysplasia, and hyperplasia / hyperkeratosis) increased by 4% between 2007 (828) and 2014 (862)
- Number of diagnosed dysplasia, CIS and SCC via the BC OBS increased by 28% between 2007 (329) and 2014 (422)
- Number of dental practitioners performing biopsies increased by 12% between 2007 (154) and 2014 (172)
Primary Source Document
Contact information of developer(s) and/or implementer(s)
Health Issue(s) that is/are addressed by the Intervention
Specific Activities of the Intervention
Priority/Target Population for Intervention Delivery
Expertise Required for Implementation within the Context of the Intervention
Are there supports available for implementation?
Are there resources and/or products associated with the interventions?